Patents by Inventor Virginie Escriou

Virginie Escriou has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • NUCLEIC ACID VECTOR TABLETS
    Publication number: 20200163879
    Abstract: The invention relates to a process for the manufacture of a tablet comprising a nucleic acid vector.
    Type: Application
    Filed: May 9, 2018
    Publication date: May 28, 2020
    Inventors: VIRGINIE BUSIGNIES-GODDIN, PASCAL BIGEY, CHRISTINE CHARRUEAU, VIRGINIE ESCRIOU, PIERRE TCHORELOFF
  • Vectors including an anionic macromolecule and a cationic lipid for delivering small nucleic acids
    Patent number: 9572776
    Abstract: The invention relates to a composition including (1) an anionic macromolecule except nucleic acids, (2) a cationic lip, and (3) a nucleic acid having a size lower than or equal to 200 nucleotides, such as an interference RNA, and to the use thereof in gene therapy.
    Type: Grant
    Filed: January 20, 2010
    Date of Patent: February 21, 2017
    Assignees: CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS), UNIVERSITE PARIS DESCARTES, INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM)
    Inventors: Virginie Escriou, Pascal Bigey, Daniel Scherman
  • VECTORS INCLUDING AN ANIONIC MACROMOLECULE AND A CATIONIC LIPID FOR DELIVERING SMALL NUCLEIC ACIDS
    Publication number: 20120093915
    Abstract: The invention relates to a composition including (1) an anionic macromolecule except nucleic acids, (2) a cationic lip, and (3) a nucleic acid having a size lower than or equal to 200 nucleotides, such as an interference RNA, and to the use thereof in gene therapy.
    Type: Application
    Filed: January 20, 2010
    Publication date: April 19, 2012
    Inventors: Virginie Escriou, Pascal Bigey, Daniel Scherman